TABLE 6

Univariate analysis for survival at diagnosis of chronic pulmonary aspergillosis (CPA)

Parameter	Hazard ratio	Standard error	p-value	95% confidence interval
Sex	0.762	0.319	0.518	0.335–1.733
Geographical origin	1.596	0.609	0.220	0.755–3.373
Age at sarcoidosis diagnosis	1.030	0.016	0.065	0.998–1.062
Age at stage 4 diagnosis	1.036	0.016	0.029	1.003–1.069
Age at CPA diagnosis	1.054	0.017	0.002	1.020–1.090
Diabetes mellitus	2.902	1.285	0.016	1.218–6.915
Extrapulmonary manifestations	0.980	0.803	0.806	0.834–1.150
Pulmonary hypertension	3.425	1.306	0.001	1.621–7.235
FEV₁	0.979	0.011	0.069	0.958–1.001
FVC	0.965	0.011	0.003	0.944–0.988
D_LCO	0.968	0.010	0.003	0.947–0.988
CPI 40	0.293	0.147	0.015	0.109–0.784
MPA/AAD >1	2.347	1.020	0.050	1.001–5.501
CT fibrosis >20%	2.710	1.096	0.014	1.226–5.990
CT fibrosis extent	1.041	0.012	0.001	1.017–1.066
Walsh's algorithm	3.069	1.696	0.042	1.038–9.068

FEV₁: forced expiratory volume in 1 s; FVC: forced vital capacity; D_LCO: diffusing capacity of the lung for carbon monoxide; CPI: composite physiological index; MPA/AAD: main pulmonary artery/ascending aorta diameter ratio; CT: computed tomography.